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 I. General Procedures. Unless otherwise stated, reactions were performed under a nitrogen atmosphere using freshly 
dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), acetonitrile (MeCN), dimethylformamide (DMF), 
and toluene (PhMe) were dried by passing through activated alumina columns. 1,4-Dioxane was dried by passing through 
activated alumina columns or purchased from Sigma-Aldrich (>99.8%, anhydrous). Triethylamine (Et3N), 
diisopropylamine (i-Pr2NH), diisopropylethylamine (i-Pr2NEt), and dicyclohexylmethylamine (Cy2NMe) were distilled 
over calcium hydride prior to use. Unless otherwise stated, chemicals and reagents were used as received. All reactions 
were monitored by thin-layer chromatography using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were 
visualized by UV, p-anisaldehyde, or KMnO4 staining. Flash column chromatography was performed using silica gel 
(particle size 0.032–0.063) purchased from Silicyle. Optical rotations were measured on a Jasco P-2000 polarimeter using 
a 100 mm path-length cell at 589 nm. 1H and 13C NMR spectra were recorded on a Varian 400 MR (at 400 MHz and 101 
MHz, respectively), a Varian Inova 500 (at 500 MHz and 126 MHz, respectively), or a Varian Inova 600 (at 600 MHz and 
150 MHz, respectively), and are reported relative to internal CHCl3 (1H, δ = 7.26), MeCN (1H, δ = 1.94), CH2Cl2 (1H, δ = 
5.32) or DMSO (1H, δ = 2.50), and CDCl3 (13C, δ = 77.0), MeCN (13C, δ = 118.26), CD2Cl2 (13C, δ = 54.0) or DMSO (13C, 
δ = 40.0). Data for 1H NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicity and qualifier abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad, app = apparent. IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are 
reported in frequency of absorption (cm–1). Preparatory HPLC was performed with an Agilent 1200 Series HPLC utilizing 
an Agilent XDB-C18 5µm column (30 x 250 mm). Analytical SFC was performed with a Mettler SFC supercritical CO2 
analytical chromatography system with Chiralcel AD-H column (4.6 mm x 25 cm). HRMS were acquired using an 
Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 








6-Bromoquinoline (SI-I) was purchased from Combi-Blocks and nitrated using a known procedure1 to give SI-II.  
SI-II (500 mg, 2.0 mmol, 1.0 equiv) was dissolved in MeOH (6 mL).  Fe powder (331 mg, 5.9 mmol, 3.0 equiv) and 
concentrated HCl (2 mL) were added and the reaction was heated to 50 °C for 1 h.  Upon cooling, the reaction was 
basified with NH4OH to pH 9, filtered through celite, and extracted with EtOAc (2 x 10 mL).  The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo.  The crude material was purified 
by chromatography on silica gel (40% acetone, 60% hexanes) to provide 1p as a light yellow, amorphous solid (300 mg, 
1.3 mmol, 68% yield). 
1H NMR: (500 MHz, CDCl3) δ 8.90 (dd, J = 4.2, 1.6 Hz, 1H), 8.16 (ddd, J = 8.6, 1.5, 0.9 Hz, 1H), 7.72 (d, J = 9.0 Hz, 
1H), 7.45 (dd, J = 9.0, 0.7 Hz, 1H), 7.39 (dd, J = 8.6, 4.2 Hz, 1H), 4.68 (s, 2H);  
13C NMR: (126 MHz, CDCl3) δ 150.3, 148.1, 139.6, 133.3, 129.4, 120.7, 120.2, 118.7, 104.3;  
FTIR: (NaCl, thin film): cm-1; 3423, 3297, 3162, 1635, 1581, 1569, 1457, 1398, 1357, 1323;  




 In a glovebox, an oven-dried 2-dram vial was charged with 2-bromo-4-iodoaniline SI-III (500 mg, 1.68 mmol, 
1.00 equiv), Pd(dppf)Cl2•CH2Cl2 (69 mg, 0.08 mmol, 0.05 equiv), bis(pinacolato)diboron (448 mg, 1.77 mmol, 1.05 
equiv), KOAc (557 mg, 5.9 mmol, 3.5 equiv), and DMSO (5 mL).  The vial was sealed, removed from the glovebox and 
heated to 80 °C.  After 24 h, the reaction was cooled, filtered through a plug of Celite, and the plug was rinsed with 
EtOAc.  The resulting filtrate was then washed with water (3 x 20 mL), dried over anhydrous Na2SO4, filtered, and 
                                                
1 Bounaud, P–Y.; Smith, C. R.; Jefferson, E. A. (SGX Pharmaceuticals Inc). Bicyclic Triazoles as Protein Kinase Modulators. 





































 concentrated in vacuo.  The crude reaction mixture was purified by chromatography on silica gel (10% EtOAc, 90% 
hexanes) to give white, amorphous solid 1m (315 mg, 1.06 mmol, 63% yield). 
1H NMR: (500 MHz, CDCl3) δ 7.86 (d, J = 1.3 Hz, 1H), 7.52 (dd, J = 7.9, 1.4 Hz, 1H), 6.72 (d, J = 7.9 Hz, 1H), 1.32 (s, 
12H);  
13C NMR: (126 MHz, CDCl3) δ 146.6, 139.2, 135.0, 114.8, 108.8, 83.6, 24.8 (Boron-bearing ipso-carbon was not 
observed);  
FTIR: (NaCl, thin film): cm-1; 3477, 3368, 2977, 2930, 1616, 1594, 1385, 1372, 1319, 1143, 1098;  




 III. Preparation of Alkyne Substrates 
 
Alkyne 2 
Alkyne 2 was prepared on decagram scale according to the procedure reported by Baran and 
coworkers2 with the following modification: Zn(0)-dust (Aldrich, <10 µm, >98%) was freshly 
activated by the following procedure: Zinc powder (50 g) was added to a rapidly stirring solution of 
2% aqueous HCl and stirred for ~3 minutes. The aqueous solution was decanted and the zinc was washed in rapid 
succession with EtOH (150 mL), acetone (2 x 150 mL), and anhydrous ether (300 mL). The zinc was rapidly filtered and 
collected into a 500-mL round bottomed flask that was evacuated to <1 mmHg and dried at 80 °C for a minimum of two 
hours. The freshly activated zinc is quickly weighed out from this flask prior to the reaction. 
Alkyne 4a 
 
To a solution of alkyne 2 (500 mg, 1.5 mmol, 1.00 equiv) in CH2Cl2 (15 mL) at 0 °C was added TFA (2.0 mL).  The 
mixture was warmed to room temperature and stirred for 3 hours, after which PhMe (30 mL) was added and the reaction 
was concentrated.  The resultant oil was dissolved in THF (10 mL) and cooled to 0 °C under a positive pressure of N2.  In 
a separate flask, (L)-Boc-Phe-OH (466 mg, 1.8 mmol, 1.2 equiv) was dissolved in THF (24 mL) and cooled to 0 °C. EDC 
(337 mg, 1.8 mmol, 1.2 equiv), anhydrous HOBt (277 mg, 2.0 mmol, 1.4 equiv), and Et3N (610 µL, 4.4 mmol, 3.0 equiv) 
were added sequentially.  After stirring for 5 minutes, the alkyne was transferred via cannula.  The reaction was warmed 
to room temperature and stirred for 12 h.  The heterogeneous reaction was concentrated and purified by chromatography 
on silica gel (20% EtOAc, 80% hexanes) to provide alkyne 4a as a colorless oil (552 mg, 1.13 mmol, 77% yield). 
 
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 7.28 – 7.22 (m, 2H), 7.19 (dd, J = 7.1, 7.1 Hz, 3H), 6.77 (d, J = 6.3 Hz, 
1H), 5.16 (d, J = 5.9 Hz, 1H), 4.67 (d, J = 6.5 Hz, 1H), 4.44 (d, J = 6.1 Hz, 1H), 3.70 (s, 3H), 3.11 (dd, J = 13.9, 6.3 Hz, 
1H), 2.98 (dd, J = 12.8, 6.6 Hz, 1H), 2.73 (dd, J = 17.0, 4.0 Hz, 1H), 2.57 (dd, J = 17.1, 5.3 Hz, 1H), 1.35 (s, 9H), 0.98 – 
0.87 (m, 9H), 0.57 – 0.46 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ 170.8, 170.4, 155.2, 136.4, 129.2, 128.4, 126.7, 101.2, 85.5, 79.8, 66.9, 55.3, 52.4, 50.8, 
38.4, 28.0, 23.5, 7.2, 4.1;  
FTIR: (NaCl, thin film): cm-1; 3419, 3335, 2963, 2868, 2179, 1743, 1661, 1518, 1451, 1365;  
[a]D25 = +52.7 (c = 5.4, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 489.2779, found 489.2793.
                                                


















 Alkyne 4b 
 
Alkyne 2 (1.02 g, 3.0 mmol, 1.00 equiv) was dissolved in a 5:1 mixture of CH2Cl2:TFA (20 mL).  After one hour, 
the reaction was concentrated in vacuo and dried on high vacuum, then redissolved in 34 mL anhydrous CH2Cl2.  The 
solution was cooled to 0 °C under N2 and EDC•HCl (0.862 g, 4.5 mmol, 1.50 equiv) and HOBt•H2O (0.680 g, 4.5 mmol, 
1.50 equiv) were added sequentially. Et3N (1.88 mL, 13.5 mmol, 4.5 equiv) was then added dropwise by syringe. The 
mixture was then stirred for 5 minutes, and Boc–D–phenylalanine (1.59 g, 6.0 mmol, 2.0 equiv) was added in a single 
portion. The reaction was slowly warmed to 23 °C over 2 hours and stirring continued for 20 hours. The reaction was then 
quenched with 1 N HCl (500 mL) and extracted with EtOAc (3 x 250 mL), then the combined organics washed with 
saturated aqueous NaHCO3 (500 mL), and aqueous layer back-extracted with EtOAc (200 mL). The combined organic 
layers were then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo to afford crude dipeptide as a viscous 
oil. 
The residue was then dissolved in CH2Cl2 (50 mL) and trifluoroacetic acid (15 mL) was added dropwise by 
addition funnel at room temperature over 10 minutes. Stirring was continued for 20 minutes, then the solution was diluted 
with toluene (100 mL) and the mixture was concentrated in vacuo to afford a thick oil. The residue was then redissolved 
in MeOH (35 mL) and the mixture was cooled to 0 °C. Et3N (27 mL) was then added dropwise to the stirring solution 
over 10 minutes by addition funnel. Upon completion of the addition, the cooling bath was removed and the reaction was 
heated to 50 °C over 16 h. The mixture was cooled to 0 °C to yield a milky solution, which was filtered and washed with 
cold methanol to provide alkyne 4b as a colorless solid (771 mg, 72% yield) 
1H NMR: (500 MHz, DMSO-d6) δ 8.35 (d, J = 1.6 Hz, 1H), 8.02 (d, J = 1.0 Hz, 1H), 7.29 – 7.19 (m, 3H), 7.18 – 7.12 (m, 
2H), 4.15 (s, 1H), 3.19 – 3.11 (m, 2H), 2.88 (dd, J = 13.5, 4.9 Hz, 1H), 2.63 (dd, J = 16.9, 3.2 Hz, 1H), 2.40 (dd, J = 17.0, 
4.7 Hz, 1H), 0.91 (t, J = 7.9 Hz, 9H), 0.50 (q, J = 7.9 Hz, 6H);  
13C NMR: (126 MHz, DMSO-d6) δ 166.6, 166.0, 135.8, 130.1, 128.0, 126.7, 104.0, 83.9, 55.4, 52.6, 38.4, 24.8, 7.3, 3.9;  
FTIR: (NaCl, thin film): cm-1; 2916, 2350, 1732, 1651, 1557, 1455;  
[a]D25 = –19.4 (c = 0.28, CHCl3);   








2) EDC, HOBt•H2O, Et3N,
    Boc–D–Phe










 Alkyne 4c 
 
To a solution of alkyne 2 (550 mg, 1.5 mmol, 1.00 equiv) in THF/H2O (4 mL/2 mL) at 0 °C under a positive 
pressure of N2 was added aqueous LiOH (1 M, 1.9 mL, 1.2 equiv).  After 1 hour, the reaction was quenched by slow 
addition of 1 M HCl (3 mL) and Et2O (6 mL).  The layers were separated and the aqueous was extracted with Et2O (3 x 10 
mL).  The organics were combined, washed with brine, dried over MgSO4, filtered, and concentrated in vacuo to afford a 
colorless oil.  The oil was dissolved in 24 mL THF and cooled to 0 °C under a positive pressure of N2.  EDC (337 mg, 1.8 
mmol, 1.2 equiv), anhydrous HOBt (277 mg, 2.0 mmol, 1.4 equiv) and Et3N (610 µL, 4.4 mmol, 3.0 equiv) were added 
sequentially.  After 5 minutes of stirring, a solution of (L)-Phe-OMe•HCl  (347 mg, 1.6 mmol, 1.1 equiv) in THF (10 mL) 
was added via cannula.  The reaction was warmed to room temperature and stirred for 12 h.  The heterogeneous solution 
was concentrated and purified by chromatography on silica gel (20% EtOAc, 80% hexanes) to give white, amorphous 
solid 4c (500 mg, 1.02 mmol, 70% yield) 
 
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 7.30 – 7.20 (m, 3H), 7.10 – 7.07 (m, 2H), 6.84 (d, J = 4.9 Hz, 1H), 5.25 
(s, 1H), 4.81 (ddd, J = 7.5, 6.0, 6.0 Hz, 1H), 4.22 (d, J = 4.9 Hz, 1H), 3.67 (s, 3H), 3.13 – 3.05 (m, 2H), 2.74 (dd, J = 17.1, 
6.1 Hz, 1H), 2.65 (dd, J = 17.1, 6.5 Hz, 1H), 1.42 (s, 9H), 0.95 (t, J = 7.9 Hz, 9H), 0.55 (q, J = 7.9 Hz, 6H);  
13C NMR: (126 MHz, CDCl3) δ 171.3, 169.9, 155.3, 135.7, 129.1, 128.4, 127.0, 102.5, 85.5, 80.2, 53.4, 53.0, 52.2, 38.0, 
28.1, 23.3, 7.4, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3319, 2954, 2935, 2874, 2177, 1746, 1689, 1660, 1527, 1498, 1456, 1367, 1274, 1251, 
1172, 1048, 1017;  
[a]D25 = +39.2 (c = 4.29, CHCl3);   




To a solution of alkyne 2 (1.00 g, 2.9 mmol, 1.00 equiv) in CH2Cl2 (30 mL) at 0 °C was added TFA (4 mL).  The mixture 
was warmed to room temperature and stirred for 3 hours, after which PhMe (100 mL) was added and the reaction 
concentrated.  The resultant oil was dissolved in THF (10 mL) and cooled to 0 °C under a positive pressure of N2.  In a 
separate flask, (R)-2-hydroxy-3-methylbutanoic acid (346 mg, 2.9 mmol, 1.0 equiv) was dissolved in THF (100 mL) and 



































 mL, 8.6 mmol, 3.0 equiv) were added sequentially.  After stirring for 5 minutes, the alkyne was added to this solution 
dropwise via cannula.  The reaction was then warmed to room temperature and stirred for 12 h.  The heterogeneous 
reaction was concentrated and purified by chromatography on silica gel (100% EtOAc) to provide alkyne 4e as a colorless 
oil (995 mg, 2.9 mmol, 99% yield). 
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.43 (d, J = 7.6 Hz, 1H), 4.59 (dt, J = 8.2, 5.3 Hz, 1H), 3.89 (dd, J = 5.5, 
3.1 Hz, 1H), 3.71 (d, J = 5.6 Hz, 1H), 3.69 (s, 3H), 2.80 (dd, J = 17.2, 5.5 Hz, 1H), 2.73 (dd, J = 17.2, 5.2 Hz, 1H), 2.07 
(heptd, J = 6.9, 3.1 Hz, 1H), 1.01 – 0.93 (m, 12H), 0.82 (d, J = 6.9 Hz, 3H), 0.61 – 0.52 (m, 6H);  
13C NMR: (126 MHz, CD3CN) δ 174.2, 171.7, 103.6, 85.8, 76.4, 53.0, 51.4, 32.7, 23.9, 19.5, 15.9, 7.8, 5.0;  
FTIR: (NaCl, thin film): cm-1; 3385, 2952, 2863, 2176, 1744, 1653, 1507;  
[a]D25 = +89.4 (c = 3.40, CHCl3);   




 IV. Optimization of Reaction Parameters 
Optimization Procedure – In a glovebox, an oven-dried 1-dram vial was charged with 2-bromoaniline (17.2 mg, 
0.1 mmol, 1.0 equiv), alkyne 2 (68.3 mg, 0.2 mmol, 2.0 equiv), base (2.5 equiv), Pd-catalyst (0.05 equiv), and appropriate 
solvent (0.5 mL).   The vial was sealed and heated to the reported temperature while the reaction progress was monitored 
by UHPLC.  Upon consumption of the starting material (2 – 36 h), the vial was cooled and the crude reaction mixture was 
filtered through a silica plug, thoroughly washed with EtOAc, and concentrated in vacuo to provide a crude oil.    
The crude residue was dissolved in a standard solution of 2,3,5,6-tetrachloronitrobenzene in DMSO-d6, and the 
yield of 3a was determined by 1H NMR by integration relative to the internal standard. In entry 11 of Table 1, Pd2(dba)3 




 V. Substrate Scope – Characterization Data 
 
 
Glovebox-Free Procedure: For ease of reaction monitoring, the substrate scope studies were conducted in a nitrogen 
filled glovebox. However, comparable yields are readily obtained outside of the glovebox utilizing the following protocol 
– To an oven-dried, 2-dram vial was charged bromoaniline (0.30 mmol, 1.0 equiv), alkyne (0.60 mmol, 2.0 equiv), and 
Pd[P(PtBu)3]2 (0.015 mmol, 0.05 equiv). The vial was evacuated and backfilled with N2 (3 x) and anhydrous 1,4-dioxane 
(1.5 mL, 0.2 M) added via syringe. Cy2NMe (0.75 mmol, 2.5 equiv) was then added via syringe and the vial was 
submerged in a preheated oil bath at 60 °C and stirred for the indicated time below. Alternatively the vial may be sealed 
with a Teflon-lined vial cap and subsequently submerged in an oil bath. Upon cooling, the crude mixture was filtered 
through a plug of silica gel, which was subsequently rinsed with EtOAc. The filtrate was then concentrated in vacuo and 
the substrate purified via column chromatography on silica gel to provide the tryptophan derivative. 
 
General Procedure I:  In a glovebox, a 2-dram vial was charged with bromoaniline (0.3 mmol, 1.0 equiv), alkyne 2 (0.6 
mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 equiv), Pd[P(PtBu)3]2 (0.015 mmol, 0.05 equiv) and anhydrous 1,4-dioxane 
(1.5 mL, 0.2 M).  The vial was sealed and heated to 60 °C until there was complete consumption of starting material (12 – 
72 h).  In most cases the solution became cloudy as the reaction progressed.  Upon cooling, the crude mixture was filtered 
through a plug of silica, which was subsequently washed with EtOAc. The organics were concentrated and the crude 
residue was purified by chromatography on silica gel to provide the tryptophan derivative. 
 
General Procedure II:  In a glovebox, a 2-dram vial was charged with bromoaniline (0.3 mmol, 1.0 equiv), alkyne 2 (0.6 
mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 equiv), Pd[P(PtBu)3]2 (0.015 mmol, 0.05 equiv) and anhydrous 1,4-dioxane 
(1.5 mL, 0.2 M).  The vial was sealed and heated to 80 °C until there was complete consumption of starting material (12 – 
72 h).  In most cases, the solution became cloudy as the reaction progressed.  Upon cooling, the crude mixture was filtered 
through a plug of silica, which was subsequently washed with EtOAc.  The organics were concentrated and the crude 
residue was purified by chromatography on silica gel to provide tryptophan derivative. 
 
General Procedure III:  In a glovebox, a 2-dram vial was charged with bromoaniline (0.3 mmol, 1.0 equiv), alkyne 2 
(0.6 mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 equiv), Pd[P(PtBu)3]2 (0.015 mmol, 0.05 equiv) and anhydrous 1,4-
dioxane (1.5 mL, 0.2 M).  The vial was sealed and heated to 80 °C until there was complete consumption of starting 












R2Pd[P(tBu)3]2 (5 mol %)
Cy2NMe (2.5 equiv)




 mixture was filtered through a plug of silica, which was subsequently washed with EtOAc.  The organics were 
concentrated and the crude residue was dissolved in 1M TBAF in THF. After 20 minutes, aqueous NH4Cl was added and 
the reaction mixture was partitioned in a separatory funnel.  The aqueous layer was back-extracted with EtOAc (3 X 15 
mL).   The organics were then recombined, washed with brine, dried over Na2SO4, filtered, and concentrated.  The crude 
residue was purified using silica gel chromatography to provide the tryptophan derivative. 
 
Tryptophan 3a 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3a as a colorless oil (113.6 mg, 0.26 mmol, 
88% yield).   
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 8.04 (s, 1H), 7.57 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 
8.1 Hz, 1H), 7.18 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H), 7.09 (t, J = 7.4 Hz, 1H), 4.93 (d, J = 7.7 Hz, 1H), 4.57 (dd, J = 14.4, 7.1 
Hz, 1H), 3.63 (s, 3H), 3.36 – 3.18 (m, 2H), 1.36 (s, 9H), 1.05 – 0.98 (m, 9H), 0.97 – 0.89 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ 173.4, 155.1, 138.5, 132.8, 128.6, 122.4, 119.5, 119.3, 118.9, 110.8, 79.6, 54.2, 52.2, 
29.3, 28.2, 7.4, 3.7;  
FTIR: (NaCl, thin film): cm-1; 3383, 2954, 2911, 2875, 1739, 1700, 1501, 1456, 1367, 1284, 1164;  
[a]D25 = +1.4 (c = 1.4, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 433.2517, found 433.2519. 
 
Tryptophan 3b 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3b as a colorless oil (102.9 mg, 0.230 
mmol, 77% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.75 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 8.4 Hz, 
1H), 7.35 (ddd, J = 8.5, 7.1, 1.3 Hz, 1H), 7.27 (ddd, J = 7.9, 7.1, 0.9 Hz, 1H), 5.57 (d, J = 8.6 Hz, 1H), 4.40 (q, J = 7.9 Hz, 
1H), 3.54 (s, 3H), 3.37 (dd, J = 14.4, 6.7 Hz, 1H), 3.20 (dd, J = 14.4, 8.2 Hz, 1H), 2.78 (s, 3H), 1.29 (s, 9H), 1.04 – 0.83 
(m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.4, 171.0, 156.1, 138.0, 137.1, 133.7, 131.2, 125.9, 123.4, 120.4, 115.2, 80.0, 55.9, 
52.7, 28.8, 28.4, 27.0, 8.6, 6.8;  
FTIR: (NaCl, thin film): cm-1; 3396, 2954, 2912, 2874, 1704, 1498, 1366, 1279, 1217, 1163, 1018;  
[a]D25 = –5.8 (c = 0.40, CHCl3);   

















 Tryptophan 3c 
Prepared following General Procedure II (12 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% acetone) to afford 3c as a white, amorphous solid (114.3 mg, 
0.234 mmol, 78% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.21 (s, 1H), 8.32 (s, 1H), 7.30 (d, J = 8.1 Hz, 
1H), 7.07 (t, J = 7.7 Hz, 1H), 6.93 (d, J = 7.4 Hz, 1H), 5.54 (s, 1H), 4.33 (dd, J = 15.7, 7.6 Hz, 
1H), 3.59 (s, 3H), 3.36 (dd, J = 14.7, 6.1 Hz, 1H), 3.05 – 3.00 (m, 1H), 2.13 (s, 3H), 1.34 – 1.18 (m, 9H), 1.03 – 0.89 (m, 
15H);  
13C NMR: (126 MHz, CD3CN) δ 174.3, 171.1, 156.2, 141.6, 134.4, 130.5, 124.7, 122.8, 119.8, 118.5, 110.7, 79.9, 57.0, 
52.6, 29.3, 28.3, 23.8, 7.7, 4.3;  
FTIR: (NaCl, thin film): cm-1; 3313, 2953, 1700, 1672, 1506, 1367, 1168;  
[a]D25 = –18.3 (c = 1.10, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 490.2732, found 490.2719. 
 
Tryptophan 3d 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (85% hexanes, 15% EtOAc) to afford 3d as a colorless oil (102.2 mg, 0.220 
mmol, 74% yield).   
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 8.95 (s, 1H), 7.28 (d, J = 8.8 Hz, 1H), 7.03 (d, J 
= 1.5 Hz, 1H), 6.77 (dd, J = 8.8, 2.4 Hz, 1H), 5.53 (d, J = 8.2 Hz, 1H), 4.36 (dd, J = 14.6, 8.2 Hz, 1H), 3.82 (s, 3H), 3.60 
(s, 3H), 3.26 (dd, J = 14.5, 6.1 Hz, 1H), 3.08 (dd, J = 14.5, 8.2 Hz, 1H), 1.28 (s, 9H), 1.01 – 0.95 (m, 9H), 0.95 – 0.91 (m, 
6H);  
13C NMR: (126 MHz, CD3CN) δ 174.0, 156.1, 154.7, 135.2, 134.1, 130.0, 120.5, 113.3, 112.6, 101.1, 79.8, 56.3, 56.2, 
52.6, 29.8, 28.4, 7.7, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3379, 2953, 2874, 1700, 1620, 1506, 1437, 1391, 1366, 1218, 1164;  
[a]D25 = +6.3 (c = 3.75, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 407.1997, found 407.1994. 
 
Tryptophan 3e 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3e as a colorless oil (97.2 mg, 0.216 mmol, 
72% yield).    
























 1H), 6.91 (ddd, J = 8.9, 8.9, 2.2 Hz, 1H), 4.93 (d, J = 8.2 Hz, 1H), 4.53 (dd, J = 14.7, 7.0 Hz, 1H), 3.65 (s, 3H), 3.30 – 
3.14 (m, 2H), 1.35 (s, 9H), 1.05 – 0.97 (m, 9H), 0.96 – 0.88 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ 173.2, 157.7 (d, JC-F = 234.9 Hz), 155.0, 135.1 (d, JC-F = 13.4 Hz), 129.0 (d, JC-F = 9.2 
Hz), 119.6 (d, JC-F = 4.7 Hz), 111.3 (d, JC-F = 9.8 Hz), 110.8 (d, JC-F = 26.5 Hz), 103.6 (d, JC-F = 23.6 Hz), 79.7, 54.2, 
52.3, 29.5, 28.2, 7.4, 3.6;  
FTIR: (NaCl, thin film): cm-1; 3372, 2956, 2875, 1734, 1718, 1700, 1502, 1437, 1367, 1166, 1073, 1010;  
[a]D25 = +3.6 (c = 2.0, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 395.1797, found 395.1804. 
 
Tryptophan 3f 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% acetone) to afford 3f as a colorless oil (114.3 mg, 0.245 
mmol, 82% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 8.87 (s, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.17 (dd, J 
= 7.5, 0.8 Hz, 1H), 7.04 – 7.01 (m, 1H), 5.50 (d, J = 8.1 Hz, 1H), 4.37 (dd, J = 15.1, 7.9 Hz, 1H), 3.56 (s, 3H), 3.29 (dd, J 
= 14.5, 6.5 Hz, 1H), 3.12 (dd, J = 14.5, 8.0 Hz, 1H), 1.29 (s, 9H), 1.02 – 0.96 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.7, 156.1, 136.6, 135.3, 131.5, 122.6, 122.4, 120.8, 118.6, 116.9, 79.9, 56.2, 52.6, 
29.7, 28.4, 7.7, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3380, 2954, 2875, 1734, 1718, 1507, 1499, 1366, 1164;  
[a]D25 = +6.9 (c = 0.87, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 411.1501, found 411.1504. 
 
Tryptophan 3g 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3g as a colorless oil (103.9 mg, 0.222 
mmol, 74% yield).   
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 7.98 (s, 1H), 7.46 (d, J = 8.5 Hz, 1H), 7.33 (s, 
1H), 7.04 (d, J = 8.5 Hz, 1H), 4.92 (d, J = 8.1 Hz, 1H), 4.55 (dd, J = 14.7, 7.1 Hz, 1H), 3.61 (s, 3H), 3.22 (d, J = 6.6 Hz, 
2H), 1.35 (s, 9H), 1.04 – 0.97 (m, 9H), 0.94 – 0.88 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ 173.2, 155.0, 138.8, 133.9, 128.4, 127.3, 120.1, 119.7, 110.7, 79.8, 54.2, 52.3, 29.5, 28.2, 
7.4, 3.6;  
FTIR: (NaCl, thin film): cm-1; 3369, 2954, 2875, 1738, 1699, 1505, 1439, 1392, 1367, 1338, 1163, 1062;  
[a]D25 = +7.1 (c = 1.63, CHCl3);   


















Prepared following General Procedure III (36 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% acetone) to afford 3h as a colorless oil (61.2 mg, 0.245 mmol, 
52% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.33 (s, 1H), 7.54 (d, J = 7.9 Hz, 1H), 7.34 (d, J = 
7.2 Hz, 1H), 7.17 (d, J = 1.7 Hz, 1H), 7.00 (dd, J = 7.8, 7.8 Hz, 1H), 5.51 (d, J = 7.4 Hz, 1H), 4.43 (dd, J = 13.5, 7.6 Hz, 
1H), 3.64 (s, 3H), 3.23 (dd, J = 14.7, 5.4 Hz, 1H), 3.10 (dd, J = 14.7, 7.7 Hz, 1H), 1.35 (s, 9H);  
13C NMR: (126 MHz, CD3CN) δ 173.5, 156.2, 135.6, 130.0, 125.5, 125.0, 121.3, 118.9, 112.5, 105.2, 79.9, 55.3, 52.7, 
28.4, 28.3;  
FTIR: (NaCl, thin film): cm-1; 3365, 2968, 1738, 1696, 1501, 1434, 1365, 1335;  
[a]D25 = +44.0 (c = 0.385, CHCl3);   
HRMS: (MM) calc’d [M–C5H10O2]+ 297.0233, found 297.0229. 
 
Tryptophan 3i 
Prepared following General Procedure II (12 h, 80 °C).  The crude residue was purified by silica 
gel chromatography (88% hexanes, 12% EtOAc) to afford 3i as a white, amorphous solid (113.7 
mg, 0.243 mmol, 82% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.29 (s, 1H), 7.38 (dd, J = 7.8, 0.9 Hz, 1H), 7.06 
(t, J = 7.7 Hz, 1H), 7.02 (dd, J = 7.5, 1.2 Hz, 1H), 5.41 (d, J = 7.7 Hz, 1H), 4.53 (dd, J = 15.2, 8.8 Hz, 1H), 3.61 (s, 3H), 
3.55 (dd, J = 14.3, 5.7 Hz, 1H), 3.28 – 3.17 (m, 1H), 1.23 (s, 9H), 1.02 – 0.89 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.8, 156.1, 141.7, 136.0, 125.8, 125.7, 123.5, 121.1, 120.4, 111.4, 79.8, 57.2, 52.5, 
29.8, 28.3, 7.7, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3369, 2954, 2934, 2875, 1721, 1700, 1499, 1456, 1436, 1366, 1167;  
[a]D25 = –9.0 (c = 4.1, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 411.1501, found 411.1505. 
 
Tryptophan 3j 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3j as a colorless oil (109.1 mg, 0.188 
mmol, 72% yield).   
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.36 (s, 1H), 7.25 (dd, J = 10.0, 7.1 Hz, 1H), 
5.58 (d, J = 8.4 Hz, 1H), 4.32 (dd, J = 14.7, 8.5 Hz, 1H), 3.59 (s, 3H), 3.24 (dd, J = 14.7, 6.0 Hz, 1H), 3.04 (dd, J = 14.6, 























 13C NMR: (126 MHz, CD3CN) δ 173.5, 156.0, 147.0 (dd, JC-F = 236.4, 11.9 Hz), 139.5 – 137.1 (m), 137.4 (d, JC-F = 3.6 
Hz), 136.2 (ddd, JC-F = 239.4, 18.9, 12.5 Hz), 125.8 (dd, JC-F = 9.1, 5.4 Hz), 124.3 (dd, JC-F = 10.4, 2.1 Hz), 122.5 – 122.1 
(m), 101.1 (d, JC-F = 19.1 Hz), 79.9, 56.2, 52.7, 29.4, 28.3, 7.6, 4.0;  
FTIR: (NaCl, thin film): cm-1; 3351, 2956, 2876, 1700, 1514, 1467, 1436, 1367, 1350, 1165;  
[a]D25 = +4.2 (c = 0.65, CHCl3);   
LRMS: (ESI) calc’d [M–C4H9]+ 431.5, found 431.2. 
 
Tryptophan 3k 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (85% hexanes, 15% EtOAc) to afford 3k as a yellow oil (105.0 mg, 0.219 
mmol, 73% yield).   
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.66 (s, 1H), 8.30 (d, J = 2.0 Hz, 1H), 7.91 (dd, 
J = 8.9, 2.1 Hz, 1H), 7.66 (d, J = 8.9 Hz, 1H), 5.59 (d, J = 8.4 Hz, 1H), 4.37 (dd, J = 15.0, 8.3 Hz, 1H), 3.57 (s, 3H), 3.32 
(dd, J = 14.6, 6.3 Hz, 1H), 3.15 (dd, J = 14.6, 8.4 Hz, 1H), 1.26 (s, 9H), 1.05 – 0.92 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.5, 144.0, 142.1, 138.1, 134.1, 121.9, 119.8, 114.9, 108.6, 79.9, 56.3, 52.7, 29.6, 
28.3, 7.6, 4.0;  
FTIR: (NaCl, thin film): cm-1; 3380, 2968, 2873, 1736, 1716, 1696, 1508, 1330, 1162, 1065, 1004;  
[a]D25 = +7.9 (c = 0.75, CHCl3);   
LRMS: (ESI) calc’d [M+H]+ 478.3, found 478.3. 
 
Tryptophan 3l 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% EtOAc) to afford 3l as a white, amorphous solid (109.0 mg, 
0.238 mmol, 79% yield).   
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.48 (s, 1H), 8.03 (s, 1H), 7.51 (d, J = 8.5 Hz, 
1H), 7.38 (dd, J = 8.5, 1.5 Hz, 1H), 5.66 (d, J = 8.8 Hz, 1H), 4.35 (td, J = 9.0, 5.5 Hz, 1H), 3.62 (s, 3H), 3.31 (dd, J = 
14.6, 5.4 Hz, 1H), 3.10 (dd, J = 14.6, 9.2 Hz, 1H), 1.23 (s, 9H), 1.00 – 0.93 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.5, 155.9, 141.4, 136.8, 129.6, 126.0, 125.3, 122.3, 121.8, 113.0, 102.4, 79.8, 56.5, 
52.7, 29.6, 28.3, 7.6, 4.0;  
FTIR: (NaCl, thin film): cm-1; 3350, 2953, 2878, 2218, 1728, 1696, 1508, 1370, 1167;  
[a]D25 = –2.3 (c = 2.2, CHCl3);   
















 Tryptophan 3m 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica 
gel chromatography (85% hexanes, 15% EtOAc – 80% hexanes, 20% EtOAc) to afford 3m 
as a white, amorphous solid (127.0 mg, 0.227 mmol, 76% yield).   
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 8.10 – 7.98 (m, 2H), 7.61 (d, J = 8.2 Hz, 
1H), 7.33 (d, J = 8.2 Hz, 1H), 4.90 (d, J = 8.1 Hz, 1H), 4.56 (dd, J = 14.4, 6.7 Hz, 1H), 
3.75 (s, 3H), 3.31 (qd, J = 14.5, 6.5 Hz, 2H), 1.36 (d, J = 2.8 Hz, 12H), 1.32 (s, 9H), 1.03 – 
0.97 (m, 9H), 0.96 – 0.90 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ173.1, 155.2, 140.5, 133.1, 128.6, 128.4, 126.7, 120.1, 110.2, 83.4, 79.5, 54.0, 52.3, 28.8, 
28.2, 24.9, 7.4, 3.7 (carbon adjacent to boron was not observed);  
FTIR: (NaCl, thin film): cm-1; 3379, 2976, 2874, 1741, 1700, 1499, 1351, 1146;  
[a]D25 = +15.0 (c = 1.0, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 558.3406, found 558.3388. 
 
Tryptophan 3n 
Prepared following General Procedure I (12 h).  The crude residue was purified by silica gel 
chromatography (98% dichloromethane, 2% methanol) to afford 3n as a light yellow oil (111.2 mg, 
0.256 mmol, 85% yield).    
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 9.76 (d, J = 14.4 Hz, 1H), 8.28 (d, J = 3.8 Hz, 1H), 
7.90 (d, J = 7.7 Hz, 1H), 7.03 (dd, J = 7.7, 4.8 Hz, 1H), 5.14 (d, J = 8.4 Hz, 1H), 4.59 (dd, J = 15.0, 7.1 Hz, 1H), 3.59 (s, 
3H), 3.25 (d, J = 6.8 Hz, 2H), 1.33 (s, 9H), 1.02 – 0.88 (m, 15H);  
13C NMR: (126 MHz, CDCl3) δ173.3, 155.0, 150.8, 143.3, 134.0, 127.3, 120.9, 118.0, 115.2, 79.7, 54.2, 52.2, 29.8, 28.1, 
7.3, 3.6;  
FTIR: (NaCl, thin film): cm-1; 3380, 3226, 2953, 1743, 1691, 1582, 1496, 1439, 1367, 1283, 1172;  
[a]D25 = +8.7  (c = 2.5, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 434.2470, found 434.2490. 
 
Tryptophan 3p 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (98% dichloromethane, 2% methanol) to afford 3p as a light yellow oil (119.5 
mg, 0.249 mmol, 83% yield).    



























 (ddd, J = 8.3, 1.5, 0.7 Hz, 1H), 7.86 (d, J = 8.9 Hz, 1H), 7.63 (dd, J = 8.9, 0.8 Hz, 1H), 7.47 (dd, J = 8.3, 4.3 Hz, 1H), 5.60 
(d, J = 8.3 Hz, 1H), 4.40 (dd, J = 15.0, 7.8 Hz, 1H), 3.57 (s, 3H), 3.37 (dd, J = 14.5, 6.6 Hz, 1H), 3.22 (dd, J = 14.5, 8.0 
Hz, 1H), 1.26 (s, 9H), 1.01 (s, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.8, 156.1, 148.6, 147.4, 133.9, 133.3, 130.0, 125.6, 123.3, 123.1, 122.0, 121.2, 
117.8, 79.9, 56.6, 52.7, 29.5, 28.3, 7.8, 4.4;  
FTIR: (NaCl, thin film): cm-1; 3350, 2953, 2873, 1734, 1717, 1700, 1696, 1570, 1496, 1377, 1164;  
[a]D25 = +8.7 (c = 1.2, CHCl3);   
HRMS: (MM) calc’d [M+H]+484.2626, found 484.2621. 
 
Tryptophan 3q 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3q as a colorless foam (103.2 mg, 0.213 
mmol, 71% yield).  
1H NMR: (500 MHz, CDCl3, Major Rotamer) δ 8.67 (s, 1H), 8.05 (d, J = 8.1 Hz, 1H), 7.92 (d, J 
= 8.0 Hz, 1H), 7.64 (d, J = 8.7 Hz, 1H), 7.53 (ddd, J = 8.2, 6.9, 1.3 Hz, 1H), 7.49 (d, J = 8.7 Hz, 1H), 7.44 (ddd, J = 8.1, 
7.0, 1.1 Hz, 1H), 4.97 (d, J = 7.9 Hz, 1H), 4.61 (app q, J = 7.1 Hz, 1H), 3.62 (s, 3H), 3.34 (d, J = 6.8 Hz, 2H), 1.35 (s, 
9H), 1.08 – 1.02 (m, 9H), 1.02 – 0.97 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ173.3, 155.1, 133.6, 130.7, 130.6, 128.8, 125.4, 124.6, 124.2, 121.4, 121.3, 120.4, 119.4, 
118.9, 79.7, 54.4, 52.2, 28.2, 24.7, 7.5, 3.8;  
FTIR: (NaCl, thin film): cm-1; 3409, 3350, 2953, 2868, 1743, 1694, 1501, 1392, 1362, 1165;  
[a]D25 = +54.8 (c = 0.97, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 427.2048, found 427.2066. 
 
Tryptophan 3r 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (88% hexanes, 12% EtOAc) to afford 3r as a colorless oil (70.1 mg, 0.156 mmol, 
52% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.51 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.3 Hz, 1H), 
7.20 (ddd, J = 8.2, 6.9, 1.1 Hz, 1H), 7.04 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H), 5.41 (d, J = 7.3 Hz, 1H), 4.33 (dd, J = 15.1, 7.5 
Hz, 1H), 3.83 (s, 3H), 3.52 (s, 3H), 3.33 (dd, J = 14.6, 7.1 Hz, 1H), 3.18 (dd, J = 14.5, 7.4 Hz, 1H), 1.31 (s, 9H), 1.03 – 
0.95 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.9, 156.1, 141.0, 135.5, 129.6, 123.1, 121.8, 119.6, 119.5, 110.2, 79.9, 56.4, 52.5, 
33.8, 28.9, 28.4, 7.9, 5.2;  













 [a]D25 = +4.9 (c = 0.34, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 391.2048, found 391.2034. 
 
Tryptophan 3s 
Prepared following General Procedure III (12 h).  The crude residue was purified by silica gel 
chromatography (20% acetone, 80% hexanes) to afford 3s as a colorless oil (80.2 mg, 0.203 mmol, 
68% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.63 (d, J = 7.8 Hz, 1H), 7.58 – 7.50 (m, 5H), 7.41 
– 7.35 (m, 1H), 7.31 (s, 1H), 7.22 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 
5.58 (d, J = 7.8 Hz, 1H), 4.51 (dd, J = 13.5, 7.7 Hz, 1H), 3.67 (s, 3H), 3.31 (dd, J = 14.7, 5.4 Hz, 1H), 3.18 (dd, J = 14.7, 
7.6 Hz, 1H), 1.35 (s, 9H);  
13C NMR: (126 MHz, CD3CN) δ 173.6, 156.3, 140.4, 136.7, 130.7, 130.0, 127.8, 127.3, 124.8, 123.5, 121.1, 120.0, 
113.0, 111.4, 79.9, 55.2, 52.7, 28.4;  
FTIR: (NaCl, thin film): cm-1; 3380, 2966, 2930, 1741, 1714, 1501, 1455, 1367;  
[a]D25 = +32.1 (c = 1.86, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 339.1339, found 339.1326. 
 
Tryptophan 3t 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (86% hexanes, 14% EtOAc) to afford 3t as a colorless oil (107.0 mg, 0.226 mmol, 
75% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.75 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 
7.35 (ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.27 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 5.57 (d, J = 8.3 Hz, 1H), 4.40 (dd, J = 15.2, 8.0 
Hz, 1H), 3.54 (s, 3H), 3.37 (dd, J = 14.4, 6.7 Hz, 1H), 3.20 (dd, J = 14.3, 8.2 Hz, 1H), 2.78 (s, 3H), 1.30 (s, 9H), 1.00 – 
0.89 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.4, 171.0, 156.1, 138.0, 137.1, 133.7, 131.2, 125.9, 123.4, 120.4, 115.2, 80.0, 55.9, 
52.7, 28.8, 28.4, 27.0, 8.6, 6.8;  
FTIR: (NaCl, thin film): cm-1; 3373, 2953, 2874, 1746, 1700, 1499, 1435, 1369, 1321, 1223, 1167, 1109;  
[a]D25 = +5.0 (c = 0.69, CHCl3);   
HRMS: (MM) calc’d [M–C4H9]+ 419.1997, found 419.1986. 
 
Tryptophan 3u 
Prepared following General Procedure III (24 h).  The crude residue was purified by silica gel 
chromatography (25% acetone, 75% hexanes) to afford 3u as a colorless oil (68.9 mg, 0.216 mmol, 














 1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 7.60 (d, J = 7.2 Hz, 1H), 7.58 (s, 1H), 7.49 (d, J = 8.1 Hz, 1H), 7.32 
(ddd, J = 8.3, 7.3, 1.4 Hz, 1H), 7.27 (td, J = 7.5, 1.0 Hz, 1H), 5.63 (d, J = 6.5 Hz, 1H), 4.48 (dd, J = 13.5, 7.9 Hz, 1H), 
3.67 (s, 3H), 3.20 (dd, J = 14.8, 5.3 Hz, 1H), 3.07 (dd, J = 14.8, 8.0 Hz, 1H), 1.35 (s, 9H);  
13C NMR: (126 MHz, CD3CN) δ 173.2, 156.0, 144.1, 128.8, 125.4, 123.6, 120.7, 116.7, 112.2, 80.0, 54.5, 52.8, 28.4, 
26.6;  
FTIR: (NaCl, thin film): cm-1; 3375, 2977, 2925, 1744, 1716, 1690, 1505, 1455, 1367, 1165;  
[a]D25 = +16.8 (c = 0.64, CHCl3);   
LRMS: (ESI) calc’d [M–C4H9]+ 263.2, found 263.2. 
 
Tryptophan 5a 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% acetone) to afford 5a as a colorless oil (109.1 mg, 0.188 
mmol, 63% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.12 (s, 1H), 7.59 (dd, J = 7.9, 0.8 Hz, 1H), 
7.39 (d, J = 8.1 Hz, 1H), 7.29 – 7.19 (m, 3H), 7.16 – 7.05 (m, 3H), 7.04 (ddd, J = 9.0, 5.6, 1.8 Hz, 1H), 5.44 (d, J = 6.4 
Hz, 1H), 4.62 (dd, J = 13.1, 6.8 Hz, 1H), 4.24 (ddd, J = 8.4, 8.4, 5.7 Hz, 1H), 3.48 (s, 3H), 3.24 (dd, J = 14.4, 7.8 Hz, 1H), 
3.10 (dd, J = 14.4, 7.9 Hz, 1H), 2.85 (dd, J = 13.9, 5.4 Hz, 1H), 2.62 (dd, J = 13.9, 8.5 Hz, 1H), 1.33 (s, 9H), 1.03 – 0.88 
(m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 173.1, 172.1, 156.2, 139.8, 138.3, 133.3, 130.2, 129.7, 129.1, 127.4, 122.8, 120.4, 
119.8, 119.4, 112.0, 79.9, 56.2, 55.4, 52.6, 38.4, 29.7, 28.4, 7.7, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3380, 2948, 2878, 1736, 1666, 1506, 1367, 1244, 1165;  
[a]D25 = –4.2 (c = 1.6, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 580.3201, found 580.3206. 
 
Tryptophan 5b 
Prepared following General Procedure I (72 h).  The crude residue was purified by silica gel 
chromatography (55% hexanes, 40% EtOAc, 5% methanol) to afford 5b as a colorless oil (95.2 mg, 
0.213 mmol, 71% yield).    
1H NMR: (500 MHz, CDCl3) δ 8.15 (s, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.36 – 7.32 (m, 2H), 7.29 
(ddd, J = 6.3, 5.1, 2.1 Hz, 2H), 7.22 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 7.18 (dd, J = 8.0, 1.2 Hz, 2H), 7.10 (ddd, J = 7.9, 7.0, 
0.9 Hz, 1H), 6.94 (d, J = 2.2 Hz, 1H), 5.64 (s, 1H), 4.24 (ddd, J = 5.2, 5.2, 2.5 Hz, 1H), 3.59 (dd, J = 14.5, 3.8 Hz, 1H), 
3.45 (dd, J = 11.5, 3.8 Hz, 1H), 3.14 (d, J = 5.1 Hz, 2H), 2.87 (dd, J = 14.5, 11.5 Hz, 1H), 1.02 – 0.94 (m, 9H), 0.90 – 





















 13C NMR: (126 MHz, CDCl3) δ 168.8, 167.0, 138.7, 134.8, 133.9, 129.9, 128.9, 127.6, 127.6, 122.8, 119.7, 118.7, 118.0, 
111.1, 56.6, 53.3, 40.2, 30.0, 7.4, 3.7;  
FTIR: (NaCl, thin film): cm-1; 3356, 3226, 2958, 2864, 1676, 1451, 1437, 1316;  
[a]D25 = +5.6 (c = 0.47, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 448.2415, found 448.2426. 
 
Tryptophan 5c 
Prepared following General Procedure I (36 h).  The crude residue was purified by silica gel 
chromatography (80% hexanes, 20% acetone) to afford 5c as a colorless oil (108.0 mg, 0.186 
mmol, 62% yield). 
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.09 (s, 1H), 7.59 (dd, J = 7.9, 0.8 Hz, 1H), 
7.40 (d, J = 8.1 Hz, 1H), 7.29 – 7.19 (m, 3H), 7.16 – 7.05 (m, 3H), 7.05 – 7.01 (m, 1H), 6.69 (d, J = 6.1 Hz, 1H), 5.24 (d, 
J = 6.4 Hz, 1H), 4.62 (q, J = 6.8 Hz, 1H), 4.23 (dt, J = 8.4, 5.7 Hz, 1H), 3.59 (s, 3H), 3.24 (ddd, J = 14.4, 6.5, 4.7 Hz, 1H), 
3.08 – 2.91 (m, 3H), 1.25 (s, 9H), 1.03 – 0.88 (m, 15H);  
13C NMR: (126 MHz, CD3CN) δ 172.5, 172.3, 140.0, 137.5, 133.3, 130.3, 129.5, 129.3, 127.7, 122.9, 120.9, 119.7, 
119.7, 112.0, 79.9, 57.1, 54.2, 52.7, 38.2, 29.5, 28.3, 7.7, 4.2;  
FTIR: (NaCl, thin film): cm-1; 3370, 2953, 2878, 1745, 1666, 1508, 1449, 1370, 1241, 1170;  
[a]D25 = +10.0 (c = 1.06, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 580.3201, found 580.3206. 
 
Tryptophan 5d 
Prepared following General Procedure I (72 h).  The crude residue was purified by silica gel 
chromatography (55% hexanes, 40% EtOAc, 5% methanol) to afford 5d as an amorphous, white 
solid (98.6 mg, 0.249 mmol, 83% yield).    
1H NMR: (500 MHz, CDCl3) δ 8.12 (s, 1H), 7.56 (dd, J = 7.9, 0.7 Hz, 1H), 7.40 (ddd, J = 8.2, 0.8, 
0.8 Hz, 1H), 7.22 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.11 (ddd, J = 8.0, 7.0, 0.9 Hz, 1H), 5.59 (s, 1H), 
4.42 (dd, J = 11.8, 2.4 Hz, 1H), 4.07 (dd, J = 11.6, 4.5 Hz, 1H), 3.84 (dd, J = 15.0, 3.9 Hz, 1H), 3.75 – 3.66 (m, 1H), 3.65 
– 3.54 (m, 1H), 3.00 (dd, J = 15.0, 11.8 Hz, 1H), 2.39 – 2.29 (m, 1H), 2.13 – 2.00 (m, 2H), 1.99 – 1.87 (m, 1H), 1.04 – 
0.98 (m, 9H), 0.94 – 0.85 (m, 6H);  
13C NMR: (126 MHz, CDCl3) δ 169.0, 165.7, 138.8, 133.6, 127.9, 123.0, 119.9, 118.8, 118.3, 111.3, 59.2, 54.8, 45.4, 
28.4, 27.5, 22.6, 7.4, 3.8;  
FTIR: (NaCl, thin film): cm-1; 3365, 2953, 2873, 1671, 1456, 1412, 1303, 1239;  
[a]D25 = –34.4 (c = 0.82, CHCl3);   





















 Tryptophan 5e 
Prepared following General Procedure II (0.87 mmol scale, 12 h).  The crude residue was 
purified by silica gel chromatography (100% EtOAc) to afford 5e as a light yellow oil (370.2 
mg, 0.756 mmol, 86% yield).    
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 9.25 (s, 1H), 8.40 (s, 1H), 7.31 (d, J = 8.1 Hz, 
1H), 7.14 (d, J = 5.6 Hz, 1H), 7.08 (t, J = 7.8 Hz, 1H), 6.92 (d, J = 7.4 Hz, 1H), 4.49 (dt, J = 10.3, 6.3 Hz, 1H), 3.61 (s, 
3H), 3.62 – 3.58 (m, 1H), 3.55 (d, J = 5.9 Hz, 1H), 3.41 (dd, J = 14.7, 6.2 Hz, 1H), 3.14 (dd, J = 14.7, 10.3 Hz, 1H), 2.16 
(s, 3H), 1.88 – 1.76 (m, 1H), 1.07 – 0.94 (m, 15H), 0.82 (d, J = 6.9, 3H), 0.66 (d, J = 6.8 Hz, 3H);  
13C NMR: (126 MHz, CD3CN) δ 174.4, 173.6, 171.5, 141.7, 134.9, 130.2, 124.9, 122.9, 119.4, 118.9, 110.9, 76.3, 52.6, 
32.6, 29.5, 29.3, 23.8, 19.4, 15.6, 7.7, 4.3;  
FTIR: (NaCl, thin film): cm-1; 3324, 2956, 2875, 1742, 1657, 1516, 1435, 1369;  
[a]D25 = –1.8 (c = 1.3, CHCl3);   














 VI.  Stability of the Tryptophan Stereocenter 
In order to confirm that the tryptophan products were not undergoing deleterious racemization under the reaction 
conditions, tryptophan 3a was desilylated with 1 N HCl/MeOH and compared to racemic N-Boc-tryptophan methyl ester 
using chiral supercritical fluid chromatography (SFC) (AD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm):  tR(minor) = 
19.6 min, tR(major) = 21.2 min.  We observed no racemization of the tryptophan stereocenter under the reaction 
conditions.  Additionally, Larock indole syntheses using dipeptide-derived alkynes to provide tryptohans 5a – 5b show 
the formation of a single diastereomer of product by crude 1H NMR and LCMS, further supporting the stability of the 
tryptophan stereocenter under Larock conditions.  The low optical rotations exhibited by tryptophans 3a – 3u are 





                                                
3 Ma, B.; Banerjee, B.; Litvinov, D. N.; He, L.; Castle, S. L. J. Am. Chem. Soc. 2009, 132, 1159. 































In a glovebox, pyridyl aniline 1n (865 mg, 5.0 mmol, 1.0 equiv), alkyne 2 (2.56 g, 7.5 mmol, 1.5 equiv), Pd[P(tBu)3]2 (64 
mg, 0.125 mmol, 0.025 equiv), and Cy2NMe (2.7 mL, 12.5 mmol, 2.5 equiv) were combined in a 50 mL flask.  The solids 
were dissolved in 15 mL 1,4-dioxane and the solution was heated to an internal temperature of 60 °C for 30 h.5  Upon 
cooling, the milky yellow solution was filtered through a silica plug, which was washed thoroughly with EtOAc.  The 
solution was concentrated and then redissolved in 50 mL EtOAc and 1 M TBAF in THF (5 mL).  After 20 minutes, 
aqueous NH4Cl was added and the reaction mixture was partitioned in a separatory funnel.  The aqueous layer was back 
extracted with EtOAc (3 x 150 mL).   The organics were then recombined, washed with brine, dried over Na2SO4, filtered 
and concentrated.  The crude residue was purified using silica gel chromatography (60% hexanes, 35% EtOAc, 5% 
methanol) to afford tryptophan 3o as a light yellow solid (1.28 g, 80% yield). 
 
1H NMR: (500 MHz, CD3CN, Major Rotamer) δ 10.06 (s, 1H), 8.23 (dd, J = 4.8, 1.5 Hz, 1H), 7.90 (dd, J = 7.9, 1.5 Hz, 
1H), 7.20 (s, 1H), 7.06 (dd, J = 7.9, 4.7 Hz, 1H), 5.64 (d, J = 8.3 Hz, 1H), 4.45 (dd, J = 5.4, 7.8 Hz, 1H), 3.64 (s, 3H), 3.23 
(dd, J = 14.7, 5.4 Hz, 1H), 3.11 (dd, J = 14.7, 7.5 Hz, 1H), 1.34 (s, 9H);  
13C NMR: (126 MHz, CD3CN) δ 173.6, 156.2, 149.6, 143.8, 127.8, 125.0, 120.7, 116.3, 109.9, 79.9, 55.3, 52.7, 28.4, 
28.4;  
FTIR: (NaCl, thin film): cm-1; 3365, 2978, 1743, 1698, 1511, 1434, 1362;  
[a]D25 = 49.1 (c = 1.25, CHCl3);   
HRMS: (MM) calc’d [M+H]+ 320.1605, found 320.1594. 
 
  
                                                
5 For larger scale preparations (>1.00 mmol) maintaining an internal temperature > 60 °C is critical for conversion. 
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 VIII.  Total Synthesis of (–)-Aspergilazine A 
Preparation of Diarylamine 8 
 
 
 In a glove box, a flame-dried 250 mL flask was charged with iodobromobenzene (6) (771 µL, 6.0 mmol, 1.0 
equiv), dianiline 7 (1.34 g, 7.2 mmol, 1.2 equiv), Pd2(dba)3 (54 mg, 0.06 mmol, 0.01 equiv), rac-BINAP (75 mg, 0.12 
mmol, 0.02 equiv), and NaOtBu (865 mg, 9.0 mmol, 1.5 equiv). PhMe (60 mL) was added and the reaction flask was 
sealed and heated to 70 °C for 3.5 hours.  Upon cooling, the reaction mixture was filtered through a plug of silica gel, 
which was flushed with EtOAc.  The organics were concentrated and purified by silica gel chromatography (20% acetone, 
80% hexanes) to provide the diarylamine 8 as a light yellow oil (1.54 g, 75% yield). 
 
1H NMR: (500 MHz, CDCl3) δ 7.62 (dd, J = 8.0, 1.4 Hz, 1H), 7.39 (d, J = 8.5 Hz, 1H), 7.34 (dd, J = 8.2, 1.6 Hz, 1H), 
7.26  (ddd, J = 8.2, 7.2, 1.5 Hz, 1H), 6.86 (ddd, J = 8.0, 7.2, 1.6 Hz, 1H), 6.59 (d, J = 2.5 Hz, 1H), 6.52 (dd, J = 8.5, 2.6 
Hz, 1H), 6.03 (s, 1H), 4.14 (s, 2H);  
13C NMR: (126 MHz, CDCl3) δ 144.6, 141.9, 140.7, 132.9, 132.8, 128.0, 121.2, 116.6, 112.5, 111.1, 106.3, 101.9;  
FTIR: (NaCl, thin film): cm-1; 3464, 3380, 1612, 1582, 1511, 1459, 1407, 1330, 1303, 1276;  
HRMS: (MM) calc’d [M+H]+ 340.9284, found 340.9264. 
 
Synthesis of Bis-Triethylsilyl-(–)-Aspergilazine A 
 
 
In a glovebox, a one-dram vial was charged with diarylamine 8 (35 mg, 0.1 mmol, 1.0 equiv), alkyne 96 (94 mg, 
0.3 mmol, 3.0 equiv), Cy2NMe (55 µL, 0.25 mmol, 2.5 equiv), Pd[P(tBu)3]2 (5.2 mg, 0.01 mmol, 0.1 equiv) and 1,4-
dioxane (500 µL).  The vial was sealed and heated to 80 °C for 4 hours.  Upon cooling, the reaction mixture was filtered 
                                                
6 Kieffer, M. E.; Chuang, K. V.; Reisman, S. E. J. Am. Chem. Soc. 2013, 135, 5557. 
I NH2H2N
NaOt-Bu (2.0 equiv)





































HPd[P(tBu)3]2 (10 mol %),








 through celite, which was washed with EtOAc (15 mL).  The organics were concentrated and the crude reaction mixture 
was purified by preparative reverse phase HPLC (65–85% acetonitrile in H2O, 30 mL/min, 20 min) to give the product as 
a colorless solid (49.5 mg, 62% yield). 
 
1H NMR: (500 MHz, CD2Cl2, Major Rotamer) δ 8.41 (d, J = 11.0 Hz, 1H), 7.66 (dd, J = 8.3, 2.5 Hz, 1H), 7.64 – 7.59 (m, 
1H), 7.41 (dd, J = 7.6, 1.6 Hz, 1H), 7.17 – 7.05 (m, 3H), 6.97 – 6.89 (m, 1H), 5.65 (s, 1H), 5.50 (s, 1H), 4.55 – 4.46 (m, 
1H), 4.47 – 4.41 (m, 1H), 4.15 – 4.04 (m, 2H), 3.91 – 3.80 (m, 2H), 3.71 – 3.61 (m, 2H), 3.60 – 3.53 (m, 2H), 3.11 (ddd, J 
= 14.7, 11.7, 2.9 Hz, 1H), 3.05 (ddd, J = 14.9, 11.7, 1.4 Hz, 1H), 2.37 – 2.24 (m, 2H), 2.12 – 1.99 (m, 4H), 1.97 – 1.87 (m, 
2H), 1.11 – 1.02 (m, 9H), 1.01 – 0.93 (m, 6H), 0.92 – 0.79 (m, 9H), 0.67 – 0.50 (m, 6H);  
 
Note: The presence of rotomeric peaks complicates the analysis of the 13C NMR spectra for this compound. 
13C NMR: (126 MHz, CD2Cl2) δ 169.6, 169.6, 166.0, 165.9, 165.8, 143.1, 143.0, 139.3, 139.3, 137.4, 137.3, 136.7, 136.6, 
135.8, 135.8, 128.7, 128.5, 128.4, 128.4, 123.5, 123.5, 121.8, 121.7, 121.6, 121.6, 120.3, 120.3, 119.8, 119.7, 119.2, 
118.5, 112.5, 112.4, 111.6, 111.6, 59.8, 59.7, 55.9, 55.8, 55.6, 54.9, 45.9, 45.8, 30.2, 29.0, 28.9, 28.2, 27.6, 23.2, 23.2, 
23.1, 7.9, 7.9, 7.8, 4.9, 4.8, 4.3. 
 
1H NMR: (400 MHz, CD3CN, 25 ºC) δ 9.53 (d, J = 6.9 Hz, 1H), 7.70 (dd, J = 8.4, 4.3 Hz, 1H), 7.67 – 7.61 (m, 1H), 7.48 
(dd, J = 12.8, 1.7 Hz, 1H), 7.09 (qd, J = 5.9, 4.5, 1.9 Hz, 3H), 6.93 – 6.82 (m, 1H), 5.61 (d, J = 11.6 Hz, 1H), 5.50 (d, J = 
18.5 Hz, 1H), 4.44 (tt, J = 10.9, 4.9 Hz, 2H), 4.12 (t, J = 7.6 Hz, 2H), 3.86 – 3.70 (m, 2H), 3.64 – 3.52 (m, 2H), 3.46 (dtd, 
J = 10.7, 7.2, 6.6, 3.1 Hz, 2H), 3.13 (ddd, J = 15.0, 11.4, 8.5 Hz, 1H), 3.04 (dd, J = 14.9, 11.0 Hz, 1H), 2.19 (s, 8H), 2.04 
– 1.78 (m, 8H), 0.98 (m, 15H), 0.83 (m, 9H), 0.66 – 0.45 (m, 6H). 
 
The 1H NMR was found to coalesce in deuterated acetonitrile at 60 °C. 
1H NMR: (400 MHz, CD3CN, 60 ºC) δ 9.40 (s, 1H), 7.72 (d, J = 8.3 Hz, 1H), 7.70 – 7.63 (m, 1H), 7.48 (s, 1H), 7.22 – 
7.04 (m, 3H), 6.91 (s, 1H), 5.58 (s, 1H), 5.47 (s, 1H), 4.45 (t, J = 11.4 Hz, 2H), 4.13 (t, J = 7.7 Hz, 2H), 3.83 (d, J = 14.7 
Hz, 1H), 3.76 (dd, J = 15.0, 4.2 Hz, 1H), 3.70 – 3.57 (m, 2H), 3.48 (ddd, J = 11.6, 8.1, 3.8 Hz, 2H), 3.18 (t, J = 13.1 Hz, 
1H), 3.09 (dd, J = 14.9, 10.8 Hz, 1H), 2.29 – 2.16 (m, 2H), 2.02 – 1.81 (m, 6H), 1.23 – 0.94 (m, 15H), 0.88 (t, J = 7.7 Hz, 
9H), 0.74 – 0.51 (m, 6H). 
  
FTIR: (NaCl, thin film): cm-1; 3375, 2963, 2859, 1671, 1446, 1414;  
[a]D25 = –79.5 (c = 0.055, 1:1 DCM:MeOH);   





Synthesis of (–)-Aspergilazine A (10) 
 
Silylated compound SI-IV (49.5 mg, 0.06 mmol, 1.0 equiv) was dissolved in 1 N HCl in MeOH (10 mL) and 
allowed to stir for 15 minutes.  The reaction was quenched by addition of aqueous NaHCO3 and diluted with EtOAc.  The 
organics were removed in vacuo and the aqueous layer was extracted with EtOAc (3 X 20 mL).  The organics were 
combined, dried over Na2SO4, filtered, and concentrated.  The crude residue was purified by silica gel chromatography 
(5% MeOH, 95% CH2Cl2) to provide (–)-aspergilazine A as a colorless solid (26.0 mg, 74% yield). 
 
Spectroscopic and physical data, including 1H, 13C NMR in DMSO-d6, IR, and MS obtained for (–)-aspergilazine A 
matched that as reported during isolation by Gu et. al7 and data obtained by Sperry and co-workers.8   See below 1H and 
13C NMR data comparison.  
The sign of the optical rotation by Gu et. al was subsequently corrected by the authors from (+)- to (–)-
aspergilazine A.9 The initially reported rotation of “[a]D25 = 72.0” was revised to “[a]D25 = –72.0.” Studies toward 
aspergilazine A by Boyd and Sperry8 confirm the negative sign value (reported rotation, [a]D25 = –70.0). The obtained 
synthetic material in this report was of slightly greater magnitude [a]D25 = –90.6 (c = 0.625, 1:1 CH2Cl2:MeOH), but of 
the same sign. 
 
1H NMR: (500 MHz, DMSO-d6) δ 11.05 (s, 1H), 7.99 (s, 1H), 7.87 (s, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.67 (d, J = 7.9 Hz, 
1H), 7.47 (d, J = 8.3 Hz, 1H), 7.46 (s, 1H), 7.44 (d, J = 1.9 Hz, 1H), 7.28 (d, J = 2.3 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.14 
(dd, J = 8.2, 1.7 Hz, 1H), 7.09 (t, J = 7.4 Hz, 1H), 4.40 (t, J = 4.8 Hz, 1H), 4.36 (t, J = 5.2 Hz, 1H), 4.16 – 4.00 (m, 2H), 
3.46 – 3.29 (m, 3H), 3.33 – 3.20 (m, 3H), 3.15 (dd, J = 14.9, 5.7 Hz, 2H), 2.05 – 1.89 (m, 2H), 1.82 – 1.51 (m, 4H), 1.47 – 
1.31 (m, 2H);   
 
                                                
7 Cai, S.; Kong, X.; Wang, W.; Zhou, H.; Zhu, T.; Li, D.; Gu, Q. Tetrahedron Lett. 2012, 53, 2615. 
8 Boyd, E. M.; Sperry, J. Org. Lett. 2014, 16, 5056. 



































 13C NMR: (126 MHz, DMSO-d6) δ 169.6, 169.6, 166.0, 165.9, 136.6, 136.1, 133.5, 129.0, 128.8, 126.6, 126.2, 122.5, 
120.2, 119.9, 115.7, 111.5, 110.6, 110.2, 107.2, 59.0, 55.8, 55.7, 45.1, 28.2, 28.2, 26.3, 26.3, 22.4, 22.4;  
FTIR: (NaCl, thin film): cm-1; 3365, 3246, 2933, 1666, 1459, 1414;  
[a]D25 = –90.6 (c = 0.625, 1:1 CH2Cl2:MeOH);   
HRMS: (MM) calc’d [M+H]+ 565.2558, found 565.2555. 
 
1H NMR: (500 MHz, CD2Cl2) δ 8.71 (s, 1H), 7.82 – 7.68 (m, 1H), 7.56 (d, J = 8.3 Hz, 1H), 7.50 – 7.40 (m, 1H), 7.33 (s, 
1H), 7.23 (s, 1H), 7.21 – 7.07 (m, 4H), 6.82 (s, 1H), 5.97 (s, 1H), 4.54 – 4.39 (m, 1H), 4.39 – 4.24 (m, 1H), 4.03 (dt, J = 
13.2, 7.5 Hz, 2H), 3.74 – 3.46 (m, 4H), 3.40 (tt, J = 7.8, 3.2 Hz, 1H), 3.29 (dt, J = 10.9, 7.7 Hz, 1H), 3.20 (dd, J = 15.1, 
8.8 Hz, 1H), 3.00 (dd, J = 15.1, 9.9 Hz, 1H), 2.23 (dt, J = 9.5, 6.6 Hz, 1H), 2.20 – 2.14 (m, 1H), 1.97 – 1.79 (m, 2H), 1.78 
– 1.67 (m, 2H). 
 
13C NMR: (126 MHz, CD2Cl2) δ 170.5, 170.0, 165.9, 165.9, 137.3, 137.2, 134.8, 128.9, 128.8, 126.2, 125.5, 123.2, 







 Table S1. Comparison of 1H NMR data for Natural vs. Synthetic (-)-Aspergilazine A 
Isolation7 
(–)-Aspergilazine A 
1H NMR, 600 MHz, DMSO-d6 
This Work 
(–)-Aspergilazine A 
1H NMR, 500 MHz, DMSO-d6 
11.09 (s, 1H) 11.05 (s, 1H) 
8.00 (s, 1H) 7.99 (s, 1H) 
7.89 (s, 1H) 7.87 (s, 1H) 
7.75 (br d, J = 8.4 Hz, 1H) 7.74 (d, J = 8.4 Hz, 1H) 
7.68 (br d, J = 7.8 Hz, 1H) 7.67 (d, J = 7.9 Hz, 1H) 
7.48 (d, J = 8.2 Hz, 1H) 7.47 (d, J = 8.3 Hz, 1H) 
7.47 (s, 1H) 7.46 (s, 1H) 
7.45 (d, J = 1.9 Hz, 1H) 7.44 (d, J = 1.9 Hz, 1H) 
7.29 (d, J = 1.7 Hz, 1H) 7.28 (d, J = 2.3 Hz, 1H) 
7.16 (ddd, J = 7.7, 7.4, 1.0 1H) 7.16 (t, J = 7.6 Hz, 1H) 
7.14 (dd, J = 8.3, 1.9, 1H) 7.14 (dd, J = 8.2, 1.7 Hz, 1H) 
7.09 (ddd, J = 7.4, 7.4, 0.8 1H) 7.09 (t, J = 7.4 Hz, 1H) 
4.41 (dd, J = 4.9, 5.0 Hz, 1H) 4.40 (t, J = 4.8 Hz, 1H) 
4.37 (dd, J = 5.0, 5.0 Hz, 1H) 4.36 (t, J = 5.2 Hz, 1H) 
4.07 (dd, J = 8.3, 8.3 Hz, 2H) 4.16 – 4.00 (m, 2H) 
3.38 (m, 3H) 3.46 – 3.29 (m, 3H) 
3.26 (m, 3H) 3.33 – 3.20 (m, 3H) 
3.16 (m, 2H) 3.15 (dd, J = 14.9, 5.7 Hz, 2H) 
1.98 (m, 2H) 2.05 – 1.89 (m, 2H) 
1.65 (m, 4H) 1.82 – 1.51 (m, 4H) 




 Table S2. Comparison of 13C NMR data for Natural vs. Synthetic (–)-Aspergilazine A 
Isolation7 
(–)-Aspergilazine A 
13C NMR, 150 MHz, DMSO 
This Work 
(–)-Aspergilazine A 
13C NMR, 126 MHz, DMSO 
Chemical Shift Difference, Δδ 
169.7 169.6 0.1 
169.6 169.6 0.0 
166.0 166.0 0.0 
165.9 165.9 0.0 
136.7 136.6 0.1 
136.2 136.1 0.1 
133.6 133.5 0.1 
129.1 129.0 0.1 
128.9 128.8 0.1 
126.6 126.6 0.0 
126.3 126.2 0.1 
122.6 122.5 0.1 
120.3 120.2 0.1 
119.9 119.9 0.0 
115.8 115.7 0.1 
111.5 111.5 0.0 
110.6 110.6 0.0 
110.3 110.2 0.1 
107.2 107.2 0.0 
59.0 59.0 0.0 
59.0 59.0 0.0 
55.8 55.8 0.0 
55.7 55.7 0.0 
45.2 45.1 0.1 
45.2 45.1 0.1 
28.3 28.2 0.1 
28.3 28.2 0.1 
26.4 26.3 0.1 
26.3 26.3 0.0 
22.4 22.4 0.0 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Number of Scans 1500
Receiver Gain 30
Relaxation Delay 1.0000
Pulse Width 4.2500
Acquisition Time 1.0420
Acquisition Date 2015-02-18T16:55:16
Spectrometer Frequency 125.66
Spectral Width 31446.5
Lowest Frequency -1833.8
Nucleus 13C
Acquired Size 32768
Spectral Size 65536
S104
